Professor Elisabet Svenungsson, MD, PhD

Professor Elisabet Svenungsson, MD, PhD

The Karolinska Institute, Stockholm,

Elisabet Svenungsson is Senior Consultant and Associate Professor of Rheumatology at Karolinska University Hospital/Karolinska Institute in Stockholm. She obtained her medical education at the Karolinska Institute and is a specialist in internal medicine and rheumatology. She has, for many years, been head of the inpatient rheumatology ward at Karolinska University Hospital. Her main clinical expertise is in systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS) and cardiovascular comorbidity associated with systemic autoimmune diseases. Professor Svenungsson is Principal Investigator of the Karolinska SLE cohort, which started in 1995 and presently comprises 500 SLE patients and matched population controls. She chairs the cardiovascular study group in The Swedish Society for Rheumatology.

Professor Svenungsson´s research is based on clinical studies of the systemic autoimmune diseases, mainly SLE, APS and systemic sclerosis. The main focus of her studies has been to understand why patients with autoimmune diseases are affected with premature cardiovascular diseases (CVD). She has, for many years, taken part in genetic studies of SLE and has recently demonstrated the importance of genetic susceptibility to SLE-related CVD.

Ongoing studies are focused on CVD, autoantibodies and genetics as well as on neurological and renal manifestations and quality of life issues. Recently, Professor Svenungsson has taken a more general research interest in the pathogenesis, sub-phenotypes and diagnostic entities of systemic autoimmunity.


Consultant/Advisor: GlaxoSmithKline, UCB
Stock/Shareholder: Pfizer

Lupus Academy Foundation
Maasdijk 409
4264 AS Veen
The Netherlands
Tel: +31 (0) 416 693 925
Fax: +31 (0) 842 152 249